ZEVRA THERAPEUTICS, INC. (ZVRA) insider trading

By person

10 insiders · 15 transactions

6.4×

Neil F. McFarlane holds 6.4 times base salary in stock. $4.69M of shares against $729.17K in salary for 2025.

Salary from the company's own proxy. The shares are what Neil F. McFarlane last reported holding, valued at $11.25, the price Common Stock was last bought or sold at on the open market here, on 12 Oct 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Neil F. McFarlane

President and CEO

—

$1.20M (3) scheduled

−$1.20M

417,225

0.7026%

$4.69M

+734.5%

Rahsaan Thompson

Chief Legal & Compliance

—

$969.36K (4) scheduled

−$969.36K

37,569

0.0633%

$422.55K

—

Corey Michael Watton

Director

—

$138.38K (1) scheduled

−$138.38K

1,800

0.0030%

$20.25K

+20.0%

Joshua Schafer

CCO

—

$126.30K (2) scheduled

−$126.30K

62,278

0.1049%

$700.47K

+1,238%

Timothy J. Sangiovanni

SVP, Finance & Corp Controller

—

$42.99K (2) scheduled

−$42.99K

29,590

0.0498%

$332.81K

+285.5%

Adrian W Quartel

Chief Medical Officer

—

$40.04K (1) scheduled

−$40.04K

9,723

0.0164%

$109.36K

+232.6%

R. LaDuane Clifton

Former CFO & Treasurer

—

143,515

0.2417%

$1.61M

+654.2%

John B Bode

Director

—

123,400

0.2078%

$1.39M

+311.3%

Alvin Shih

Director

—

20,000

0.0337%

$224.95K

—

Tamara A Favorito

Director

—

3,894

0.0066%

$43.80K

+441.6%

ZEVRA THERAPEUTICS, INC.

What the insiders did Scheduled selling only

By person